These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36694108)

  • 21. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating hospital heterogeneity with a competing risks frailty model.
    Rueten-Budde AJ; Putter H; Fiocco M
    Stat Med; 2019 Jan; 38(2):269-288. PubMed ID: 30338563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-Cox model for non-proportional hazards survival analysis with frailty.
    Begun A; Kulinskaya E; Ncube N
    Stat Med; 2023 Aug; 42(18):3114-3127. PubMed ID: 37190904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.
    Danieli C; Bossard N; Roche L; Belot A; Uhry Z; Charvat H; Remontet L
    Biostatistics; 2017 Jul; 18(3):505-520. PubMed ID: 28334368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporation of nested frailties into semiparametric multi-state models.
    Rotolo F; Rondeau V; Legrand C
    Stat Med; 2016 Feb; 35(4):609-21. PubMed ID: 26381148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A dynamic frailty model for multivariate survival data.
    Yue H; Chan KS
    Biometrics; 1997 Sep; 53(3):785-93. PubMed ID: 9333346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of frailty in survival analysis.
    Aalen OO
    Stat Methods Med Res; 1994; 3(3):227-43. PubMed ID: 7820293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frailty model with change points for survival analysis.
    Kojima M; Orihara S
    Pharm Stat; 2024; 23(3):408-424. PubMed ID: 38192006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unobserved covariates in the two-sample comparison of survival times: a maximum efficiency robust test.
    Broët P; Moreau T; Lellouch J; Asselain B
    Stat Med; 1999 Jul; 18(14):1791-800; discussion 1801. PubMed ID: 10407249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parametric overdispersed frailty models for current status data.
    Abrams S; Aerts M; Molenberghs G; Hens N
    Biometrics; 2017 Dec; 73(4):1388-1400. PubMed ID: 28346819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.
    Liquet B; Timsit JF; Rondeau V
    BMC Med Res Methodol; 2012 Jun; 12():79. PubMed ID: 22702430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frailty models: Applications to biomedical and genetic studies.
    Govindarajulu US; Lin H; Lunetta KL; D'Agostino RB
    Stat Med; 2011 Sep; 30(22):2754-64. PubMed ID: 21786277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death.
    Belot A; Rondeau V; Remontet L; Giorgi R;
    Stat Med; 2014 Aug; 33(18):3147-66. PubMed ID: 24639014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small sample bias in the gamma frailty model for univariate survival.
    Barker P; Henderson R
    Lifetime Data Anal; 2005 Jun; 11(2):265-84. PubMed ID: 15938549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored.
    Cécilia-Joseph E; Auvert B; Broët P; Moreau T
    Biom J; 2015 May; 57(3):371-83. PubMed ID: 25597640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-parametric frailty Cox models for hierarchical time-to-event data.
    Gasperoni F; Ieva F; Paganoni AM; Jackson CH; Sharples L
    Biostatistics; 2020 Jul; 21(3):531-544. PubMed ID: 30590499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Goodness-of-fit tests for the frailty distribution in proportional hazards models with shared frailty.
    Geerdens C; Claeskens G; Janssen P
    Biostatistics; 2013 Jul; 14(3):433-46. PubMed ID: 23274285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frailty modelling for the excess hazard.
    Zahl PH
    Stat Med; 1997 Jul; 16(14):1573-85. PubMed ID: 9257413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond the proportional frailty model: Bayesian estimation of individual heterogeneity on mortality parameters.
    Colchero F; Kiyakoglu BY
    Biom J; 2020 Jan; 62(1):124-135. PubMed ID: 31574180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexible Bayesian excess hazard models using low-rank thin plate splines.
    Quaresma M; Carpenter J; Rachet B
    Stat Methods Med Res; 2020 Jun; 29(6):1700-1714. PubMed ID: 31502511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.